TAE Life Sciences (TLS), a leader in Boron Neutron Capture Therapy (BNCT), today announced key milestones demonstrating commercial traction, clinical adoption, and global supply chain development. The ...
HELSINKI and BOSTON, May 16, 2025 /PRNewswire/ -- Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital with ...
NEW YORK--(BUSINESS WIRE)--Aviko Radiopharmaceuticals, a Deerfield Management-founded biotechnology company, is advancing precision boron neutron capture therapy (BNCT) to treat a variety of cancers ...
— Leo Cancer Care’s upright patient positioning system to be integrated into Neutron Therapeutics’ nuBeam® therapy platform — NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Aviko Radiopharmaceuticals, a ...
A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...
Neutron capture cross section measurements at the Japan Proton Accelerator Research Complex (J-PARC) have been pivotal in advancing our understanding of nuclear reactions that underpin both ...
Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: Implications for hippocampal sparing irradiation. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback